Rescheduling cannabis to Schedule III isn’t the goal, and our work isn’t done yet. Yet, it finally cracks open a nearly ancient framework and makes way for potentially revolutionary healthcare science grounded in research while also legitimizing cannabis as medicine. We no longer have to wonder when cannabis policy will evolve; it’s now a question of when society and institutions around us will finally catch on.
The cannabis industry spent years predicting flower’s decline. Grown Rogue CEO and co-founder Obie Strickler…
Part V of our coverage of the federal rescheduling case. Part IV covered the post-hearing…
A Spanish engineer who has spent sixteen years scanning flower explains how the industry got…
Cannabis Wine Tours founder Charles Kimball argues that farmer-hosted experiences can connect visitors with the…
The slang of drug combinations is a genuine cultural product—inventive, adaptive, and revealing of how…
The creator of biohacking talks psychedelics, plant intelligence, integration, surrender, and why optimizing the human…